Monte Rosa Therapeutics Inc (GLUE)

07:14 AM

Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

07:14 AM

04:31 AM

What to do if you’re stuck in Monte Rosa Therapeutics Inc.Dividend Hike & Low Risk Investment Opportunities - newser.com

04:31 AM

03:03 AM

Is it time to cut losses on Monte Rosa Therapeutics Inc.Market Volume Report & Stock Timing and Entry Methods - newser.com

03:03 AM

02:37 AM

Is Monte Rosa Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Decliners & Accurate Technical Buy Alerts - newser.com

02:37 AM

01:47 AM

Why Monte Rosa Therapeutics Inc. stock could benefit from AI revolutionWeekly Stock Report & High Return Trade Guides - newser.com

01:47 AM

01:22 AM

Chart based exit strategy for Monte Rosa Therapeutics Inc.2025 Top Gainers & Community Verified Trade Signals - newser.com

01:22 AM

Nov 02, 2025

Forecasting Monte Rosa Therapeutics Inc. price range with options dataMarket Movers & Safe Entry Trade Reports - newser.com

Nov 02, 2025

Nov 02, 2025

Cwm LLC Raises Holdings in Monte Rosa Therapeutics, Inc. $GLUE - MarketBeat

Nov 02, 2025

Nov 01, 2025

Monte Rosa Therapeutics, Inc. (GLUE) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Nov 01, 2025

Nov 01, 2025

Monte Rosa Therapeutics, Inc. (GLUE) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Nov 01, 2025

Nov 01, 2025

Monte Rosa Therapeutics (NASDAQ:GLUE) Given Sell (D+) Rating at Weiss Ratings - MarketBeat

Nov 01, 2025

Oct 31, 2025

Monte Rosa Therapeutics Hits New 52-Week High of $13.10 - Markets Mojo

Oct 31, 2025

Oct 31, 2025

Monte Rosa Therapeutics (GLUE) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2025

Oct 31, 2025

Custom watchlist performance reports with Monte Rosa Therapeutics Inc.Bull Run & Technical Entry and Exit Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

Visual trend scoring systems applied to Monte Rosa Therapeutics Inc.Weekly Market Summary & Expert-Curated Trade Recommendations - newser.com

Oct 31, 2025

Oct 31, 2025

Why Monte Rosa Therapeutics Inc. stock is popular among millennialsJuly 2025 Outlook & Technical Pattern Alert System - newser.com

Oct 31, 2025

Oct 30, 2025

Monte Rosa Therapeutics Advances MRT-2359 in MYC-Driven Cancer Study - MSN

Oct 30, 2025

Oct 30, 2025

Monte Rosa Therapeutics Hits New 52-Week High of $12.97 - Markets Mojo

Oct 30, 2025

Oct 30, 2025

Monte Rosa Therapeutics Advances with MRT-8102: A Promising Phase 1 Study - MSN

Oct 30, 2025

Oct 30, 2025

What analysts say about Monte Rosa Therapeutics Inc stockDividend Reinvestment Plans & Small Investment Growth Tips - earlytimes.in

Oct 30, 2025

Oct 30, 2025

How Regulatory Changes Could Impact ICDS Limiteds BusinessRelative Strength Index (RSI) & Learn to Trade Without Fear of Loss - earlytimes.in

Oct 30, 2025

Oct 30, 2025

Working capital per share of Monte Rosa Therapeutics, Inc. – NASDAQ:GLUE - TradingView

Oct 30, 2025

Oct 30, 2025

Published on: 2025-10-30 01:39:11 - newser.com

Oct 30, 2025

Oct 29, 2025

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - Yahoo Finance

Oct 29, 2025

Oct 28, 2025

Monte Rosa Therapeutics (NASDAQ:GLUE) Reaches New 1-Year HighStill a Buy? - MarketBeat

Oct 28, 2025

Oct 28, 2025

Why Monte Rosa Therapeutics Inc. stock is trending among retail tradersJuly 2025 EndofMonth & Weekly High Return Stock Forecasts - fcp.pa.gov.br

Oct 28, 2025